Postconfluent multilayered cell line cultures for selective screening of gemcitabine
- 31 May 1998
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 34 (6), 921-926
- https://doi.org/10.1016/s0959-8049(97)10125-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsInvestigational New Drugs, 1996
- Phase II study of gemcitabine in previously platinum-treated ovarian cancer patientsAnti-Cancer Drugs, 1995
- Schedule dependence of sensitivity to 2′,2′-difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumoursBiochemical Pharmacology, 1994
- Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent culturesEuropean Journal of Cancer, 1993
- 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell linesBiochemical Pharmacology, 1993
- The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancerBritish Journal of Cancer, 1993
- Clinical and preclinical activity of 2′,2′- difluorodeoxycytidine (gemcitabine)Cancer Treatment Reviews, 1993
- Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter platesBritish Journal of Cancer, 1992
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- 2',2'-Difluorodeoxycytidine Metabolism and Mechanism of Action In Human Leukemia CellsNucleosides, Nucleotides and Nucleic Acids, 1989